Toshiba in the 2015 Global Diagnostic Imaging Sector
A strategic assessment of Toshiba, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostic imaging market.
Contains 116 pages and 10 tables
Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.
SIMILAR MARKET STUDIES
Summary TearLab Corporation (TearLab) is an in vitro diagnostic company. The company develops and commercializes a proprietary tear testing platform including TearLab Osmolarity System. Its TOS system allows the eye care practitioners to test biomarkers utilizing nano liters of tears at the point-of-care. TearLab’s TOS measures osmolarity of human tears for ...
February 2015 | $300 | View Details >>
This report studies sales (consumption) of Medical Nonwoven Disposables in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Ahlstrom ...
July 2016 | $4000 | View Details >>
Summary Inogen, Inc. (Inogen) is a medical device company. The company designs, develops, manufactures, markets and distributes oxygen therapy systems. Its products include g2 portable oxygen concentrator system, g3 portable oxygen concentrator system, and accessory items. Inogen’s g2 portable oxygen concentrator is a single solution oxygen concentrator and g3 portable oxygen ...
July 2014 | $250 | View Details >>
Summary VolitionRX Ltd. (VolitionRX) is a life science company. The company provides non invasive blood tests for cancer. It provides products such as NuQ and HyperGenomics. The company’s NuQ is based on proprietary Nucleosomics technology for the measurement and identification of nucleosome structures in the blood. VolitionRX also develops HyperGenomics, a ...
September 2014 | $750 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research